An amino-truncated variant form of the epidermal growth factor recepto
r (EGFRvIII) has been identified in human brain, breast, lung and ovar
ian tumors, We have found that overexpression of this mutant EGF recep
tor in NIH3T3 cells results in transformation as a result of the activ
ation of the receptor kinase via ligand-independent dimerization, Tran
sformation was correlated with tyrosine phosphorylation of only a subs
et of the proteins observed in cells overexpressing the normal EGF rec
eptor. This suggested that further studies on cells expressing the EGF
RvIII might provide insights into the pathways most relevant to transf
ormation, In clones expressing high levels of mutant EGF receptor, the
levels of both Grb2 and SHC were decreased, Despite this decrease, mu
ch of the endogenous Grb2 immunoprecipitated with EGFRvIII, Interestin
gly, no increase in ras-GTP loading was found in clones expressing the
EGFRvIII and MAP kinase assays indicated only a small increase in act
ivity, These results indicate that high-level expression of the EGFRvI
II induces downregulation of the ras-MAP kinase pathway and that other
components involved in EGF receptor signal transduction may play a gr
eater role in neoplastic transformation by the EGFRvIII.